Poster DisKussion
13:30Friday, October 9th 2009
Poster Diskussion Session I |
Florian Tomaselli, Krankenhaus Elisabethinen Linz |
|
|
P 10
|
Placement of self-expanding oesophageal stents as bridging for neoadjuvant therapy | |
| Langer Felix ( MUW) | ||
|
P 11
|
[18F]-fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemoradiation in esophageal cancer | |
| Vallböhmer Daniel (Universität zu Köln) | ||
|
P 12
|
Surgery or no surgery - how can we optimise the distinction between operable and not operable lesions of the pancreatic head? A single institution experience | |
| Thalhammer Sabine (Kaiser Franz Josef Spital) | ||
|
P 13
|
Neoadjuvante Therapie des primär operablen Magenkarzinoms mit Epirubicin / Oxaliplatin / Capecitabine (EOX) | |
| Pluschnig Ursula ( MUW) | ||
Poster Diskussion Session II |
Michael Gadenstätter, Landesklinikum Krems, NÖ |
|
|
P 20
|
Economic Impact of Oral Cancer: Duration of hospitalisation and ambulatory follow-up after complete resection of oral squamous cell carcinoma in 63 patients. | |
| Beck-Mannagetta Johann (PMU) | ||
|
P 21
|
Comparison of the proposed and current TNM staging system in bronchoplastic resection for non-small cell lung cancer | |
| End Adelheid (MUW) | ||
|
P 22
|
Breast conserving therapy after neoadjuvant treatment: Is it safe? | |
| Fitzal Florian (MUW) | ||
|
P 22a
|
Inclusion criteria for the use of neoadjuvant chemotherapy in breast cancer | |
| Fitzal Florian (MUW) | ||
|
P 23
|
Postoperative Morbidity Following Chemoradiation for Locally Advanced Low Rectal Cancer | |
| Stelzmüller Ingrid ( MUI) | ||
|
P 24
|
Neoadjuvante Lokaltherapie beim synchron metastasierten, lokal fortgeschrittenen Rektumkarzinom - Änderung der Strategie? | |
| Zitt Matthias ( MUI) | ||
Poster Diskussion Session III |
Etienne Wenzl, LKH Feldkirch |
|
|
P 30
|
Long-term survival of more than 240 patients with gastric carcinoma - a retrospective study from an oncological centre | |
| Braunschmid Tamara (Kaiser Franz Josef Spital) | ||
|
P 31
|
Extraabdominelle Lymphknotenmetastasen von gastrointestinalen Stroma-tumoren (GISTs) und ihre prognostische Bedeutung | |
| Vassos Nikolaos (Universitätsklinikum Erlangen) | ||
|
P 32
|
The correlation between p53 genotype and overall survival in patients with colorectal cancer liver metastases with and without neoadjuvant therapy: A p53 research group study | |
| Pilat Nina (MUW) | ||
|
P 33
|
Secondary resectabilty in patients with advanced or metastatic cholangiocarcinoma treated with Cetuximab plus Gemcitabine-Oxaliplatin (GEMOX): a single centre phase II study | |
| Gruenberger Birgit (KA Rudolfstiftung) | ||
|
P 34
|
Cystic neoplasms of the pancreas: Conservative or operative treatment? | |
| Akan Belgin (MUW) | ||
Poster Diskussion Session IV |
Friedrich Kober , Elisabethspital, Wien |
|
|
P 40
|
Selecting patients suffering from peritoneal carcinomatosis for an aggressive multimodal therapy: prognostic factors predicting the possibility of optimal cytoreductive surgery and long term survival | |
| Kober Friedrich ( Kaiserin Elisabeth Spital) | ||
|
P 40a
|
Blocking of RET oncogen-triggered pathways by sorafenib stops progression of disease in metastatic medullary cancer patients - long term results | |
| Kober Friedrich (Kaiserin Elisabeth Spital) | ||
|
P 41
|
Angiogenesis associated Cell Populations Increase with Neoadjuvant Bevacizumab Treatment of Metastatic Colorectal Cancer | |
| Starlinger Patrick (MUW) | ||
|
P 41a
|
Discrete Effects of Bevacizumab and Gemcitabine on the Angiogenic Balance in Neoadjuvant Therapy of Locally Advanced Pancreatic Cancer | |
| Starlinger Patrick (MUW) | ||
|
P 42
|
Oncolytic Influenza A virus induced tumor cell directed cytotxicity of PBMCs is not aborted by LPS-induced hyporesponsiveness | |
| Baumann Suzann (MUW) | ||
|
P 43
|
Impact of immune modulators on the outcome after 5-FU based therapy in microsatellite unstable colon cancer. | |
| Wolf Brigitte (MUW) | ||